EU4Health call for tenders to speed-up the development, availability and access to anti-tuberculosis medicines for children
Antimicrobial resistance (AMR) is a major threat to health, which was associated with 5 million deaths globally in 2019 and against which efficient medical countermeasures are lacking. Therefore, promoting access to medicines that could assist in the fight against antimicrobial resistance is essential. The unavailability of age-appropriate medicines for the treatment of antimicrobial-susceptible paediatric tuberculosis […]




